Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

Craig Kollman(Diabetes Australia), Dennis L. Confer(National Marrow Donor Program)

Blood

October 1, 2001

10.1182/blood.v98.7.2043

Cited by 701

Related Papers

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

|New England Journal of Medicine|2019|960

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

|Blood|2010|477

One million haemopoietic stem-cell transplants: a retrospective observational study

|The Lancet Haematology|2015|434

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome

|Blood|1996|318

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

|Bone Marrow Transplantation|2016|309